(Q37905185)

25 August 2017

0 references

Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood--a meta-analysis (English)

1 reference

25 August 2017

0 references

0 references

Katja Doege

1

1 reference

25 August 2017

Donata Grajecki

2

1 reference

25 August 2017

Birgit-Christiane Zyriax

3

1 reference

25 August 2017

Elena Detinkina

4

1 reference

25 August 2017

Christine Zu Eulenburg

5

1 reference

25 August 2017

Kai J Buhling

6

1 reference

25 August 2017

publication date

26 July 2011

1 reference

British Journal of Nutrition

25 August 2017

published in

1 reference

25 August 2017

volume

107

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

1-6

1 reference

Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

Safety of probiotics that contain lactobacilli or bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

Probiotics and prevention of allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

Examining the hygiene hypothesis: the Trial of Infant Probiotic Supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

Probiotics for the prevention or treatment of allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

7 January 2021

Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

7 January 2021

Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

7 January 2021

Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

7 January 2021

Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

7 January 2021

Increased requirements for essential fatty acids in atopic individuals: a review with clinical descriptions

1 reference

https://api.crossref.org/works/10.1017%2FS0007114511003400

7 January 2021

10.1017/S0007114511003400

Identifiers

DOI

1 reference

25 August 2017

1 reference